"



  Psychoactive Plant Database - Neuroactive Phytochemical Collection





Worldwide, there are plants known as psychoactive plants that naturally contain psychedelic active components. They have a high concentration of neuroprotective substances that can interact with the nervous system to produce psychedelic effects. Despite these plants' hazardous potential, recreational use of them is on the rise because of their psychoactive properties. Early neuroscience studies relied heavily on psychoactive plants and plant natural products (NPs), and both recreational and hazardous NPs have contributed significantly to the understanding of almost all neurotransmitter systems. Worldwide, there are many plants that contain psychoactive properties, and people have been using them for ages. Psychoactive plant compounds may significantly alter how people perceive the world.

 

Compound Summary

 

PLANT NAME:- Juglans regia     PPD ID:- PPD-ID48_326


COMPOUND/COMMON NAME:- meso-inositol
CAS ID
N/A
INCHI KEY
CDAISMWEOUEBRE-UHFFFAOYSA-N
MOLECULAR WEIGHT
180.16
MOLECULAR FORMULA
C6H12O6
MOLECULAR MASS
180.156
BIOLOGICAL SOURCE
Juglans regia
DATA SOURCE
U.S. Department of Agriculture, Agricultural Research Service. 1992-2016. Dr. Duke's Phytochemical and Ethnobotanical Databases. Home Page, http://phytochem.nal.usda.gov/ http://dx.doi.org/10.15482/USDA.ADC/1239279
CHEMICAL CLASS OF COMPOUND
Organooxygen compounds
NLRP3 DOCKING SCORE(Kcal/mol)
-6.825
CANONICAL SMILES   OC1C(O)C(O)C(O)C(O)C1O
BIOACTIVITY REPORTED FOR NEURODEGENERATIVE DISEASES   Yes
SYNONYMS
inositol, myo-inositol, Scyllo-inositol, epi-Inositol, Muco-Inositol, Allo-inositol, i-Inositol, 87-89-8, meso-Inositol, D-chiro-Inositol, Neo-inositol, 1L-Chiro-inositol, 488-59-5, 643-12-9, D-(+)-chiro-Inositol, cis-Inositol, 1D-Chiro-inositol, Myoinositol, 488-58-4, 6917-35-7, Cyclohexane-1,2,3,4,5,6-hexaol, cyclohexane-1,2,3,4,5,6-hexol, Scyllitol, 551-72-4, Quercinitol, mesoinositol, Cocositol, 41546-34-3, Meat sugar, Myoinosite, Dambose, chiro-inositol, 643-10-7, Inositene, Inositina, L-chiro-Inositol, Phaseomannite, Inosital, Inosite, Inositol, myo-, Iso-inositol, Cyclohexitol, Phaseomannitol, Mesoinosit, Mesoinosite, Scyllite, Mesovit, Nucite, Mesol, 488-55-1, D-chiro Inositol, Cyclohexanehexol, Inositol, meso-, 488-54-0, cis-1,2,3,5-trans-4,6-Cyclohexanehexol, D-myo-Inositol, Bios I, Insitolum, Isoinositol, L-(-)-chiro-Inositol, (-)-Inositol, 576-63-6, d-Inositol, L-Inositol, L-myo-Inositol, Inositol, allo-, Inositol, muco-, Inositol, i-, Inositol, scyllo-, Inositol (VAN), alloinositol, neoinositol, Hexahydroxycyclohexane, Levoinositol, scyllo-Cyclohexanehexol, 1D-myo-Inositol, 1L-myo-Inositol, Inositol, cis-, Inositol, epi-, Inositol, neo-, (1R,2R,3S,4R,5r,6S)-cyclohexane-1,2,3,4,5,6-hexaol, epi-Cyclohexanehexol, (+)-Inositol, 1,2,3,4,5,6-Cyclohexanehexol, 38876-99-2, (-)-chiro-Inositol, ELND005, Rat antispectacled eye factor, (+)-Chiro-Inositol, (1R,2R,3S,4S,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, MFCD00077932, CCRIS 6745, 1,2,3,5-trans-4,6-Cyclohexanehexol, cis-, AZD 103, Chiro-inositol, (-)-, Inositol, myo, (1r,2R,3S,4r,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol, MFCD00065455, (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexol, 1,3,5/2,4,6-Hexahydroxycyclohexane, (1R,2R,3R,4R,5S,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3R,4S,5S,6s)-cyclohexane-1,2,3,4,5,6-hexaol, 1-L-chiro-Inositol, Inositol, D-chiro-, CHEBI:17268, AI3-16111, NSC8101, 1,3,5/2,4,6-cyclohexanehexol, 1,2,3,5/4,6-Cyclohexanehexol, NSC 8101, NSC-8101, Chiro-inositol, (+)-, (1R,2R,3R,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1R,2R,3S,4S,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, 1,2,3,4,5,6-HEXAHYDROXY-CYCLOHEXANE, NSC-25142, NSC-55551, NSC404118, myo-Inositol;meso-Inositol, 1,2,3,4,5,6-Hexahydroxycyclohexane, NSC 404118, NSC-404118, J101.890F, J101.891D, (1s,2s,3s,4s,5s,6s)-cyclohexane-1,2,3,4,5,6-hexol, 63GQX5QW03, 8LQ63P85IC, 9O6Y5O4P9W, ELND-005, R1Y9F3N15A, (1r,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1s,2R,3R,4s,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, MI, DTXSID7023146, CHEBI:10642, CHEBI:23927, CHEBI:27372, CHEBI:27987, AZD-103, 4661D3JP8D, 6R79WV4R10, M94176HJ2F, Inositol (VAN8C, NSC45517, NSC55551, NSC55552, NSC-55552, NSC-55558, 1VS4X81277, NSC-103959, NSC-127230, INS, NCGC00159409-02, (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2R,3S,4R,5S,6S)-cyclohexane-1,2,3,4,5,6-hexol, (1r,2R,3S,4s,5R,6S)-cyclohexane-1,2,3,4,5,6-hexol, rel-(1r,2r,3r,4r,5r,6r)-Cyclohexane-1,2,3,4,5,6-hexaol, 4L6452S749, 587A93P465, Inositol, myo- (8CI), 1,3,4,5,6-Cyclohexanehexol, 1,3,5/4,6-Cyclohexanehexol, DTXCID2065254, (1R,2S,3r,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol, 1,2,4/3,5,6-cyclohexanehexol, (1R,2R,3S,4S,5S,6R)-CYCLOHEXANE-1,2,3,4,5,6-HEXOL, rel-(1R,2r,3S,4R,5s,6S)-Cyclohexane-1,2,3,4,5,6-hexaol, Mouse antialopecia factor, 1,2,3,4,5,6-Cyclohexanehexol #, cis-1,2,3,4,5,6-cyclohexanehexol, CAS-87-89-8, cis-1,3,5-trans-4,6-Cyclohexanehexol, SMR000857145, SMR000857319, SMR000857320, ELND 005, SR-05000001655, EINECS 201-781-2, inositols, UNII-63GQX5QW03, UNII-8LQ63P85IC, UNII-9O6Y5O4P9W, UNII-R1Y9F3N15A, Matezodambose, an inositol, Inositol [Nonspecific isomer], UNII-4661D3JP8D, UNII-6R79WV4R10, UNII-M94176HJ2F, Muscle sugar, inositol myo-, UNII-1VS4X81277, 4irx, Inositol, chiro-, rac-chiro-inositol, UNII-4L6452S749, UNII-587A93P465, Inosital (TN), Inositol (NF), CBU, EINECS 207-681-5, EINECS 207-682-0, EINECS 209-000-7, EINECS 211-393-5, EINECS 211-394-0, EINECS 230-024-9, MFCD00003863, MFCD00272608, NSC 25142, EPIINOSITOL, (+)-Epi-Inositol, CHIRO-INOSITOLS, allo-Inositol, 97%, Inositol [USAN:NF], INOSITOL, MESO, Spectrum_001595, 2os9, INOSITOL [USAN], INOSITOL [FCC], INOSITOL [INN], orthorhombic myo-inositol, D-(+)-Chiro Inositol, DL-CHIRO-INOSITOL, INOSITOL [MI], INOSITOL (D), INOSITOL (L), INOSITOL [VANDF], Spectrum3_001053, Spectrum4_001193, Spectrum5_000961, myo-Inositol, >=99%, INOSITOL [MART.], bmse000102, bmse000103, bmse000113, bmse000901, bmse000922, Epitope ID:144993, INOSITOL [USP-RS], INOSITOL [WHO-DD], scyllo-Inositol, >=98%, SCHEMBL5831, SCHEMBL5832, SCHEMBL5969, NCIOpen2_008191, BSPBio_002606, KBioGR_001885, KBioSS_002075, MLS001332377, MLS001332378, MLS001335965, MLS001335966, MLS001335967, MLS001335968, SCHEMBL187278, SCHEMBL187397, SCHEMBL187796, SCHEMBL188106, SCHEMBL188237, SCHEMBL491333, SCHEMBL959404, SCHEMBL959405, CHEMBL278373, CHEMBL468154, GTPL4495, GTPL4645, GTPL4648, GTPL4649, MEGxp0_001817, SCHEMBL1055883, SCHEMBL4748543, SCHEMBL6378921, SCHEMBL6468882, SCHEMBL6791918, CHEMBL1222251, CHEMBL1231671, CHEMBL1950780, CHEMBL3976780, SCHEMBL12371461, SCHEMBL12377889, SCHEMBL12411898, SCHEMBL12711208, SCHEMBL12735687, SCHEMBL13058696, SCHEMBL13114115, SCHEMBL13114116, SCHEMBL13114128, SCHEMBL13207905, SCHEMBL13580047, SCHEMBL14542470, SCHEMBL21388397, ACon1_002457, CHEBI:22357, CHEBI:23311, CHEBI:24848, CHEBI:25492, CHEBI:27374, D-(+)-chiro-Inositol, 95%, KBio2_002075, KBio2_004643, KBio2_007211, KBio3_001826, L-(-)-chiro-Inositol, 95%, DTXSID30110000, DTXSID50905091, myo-Inositol, p.a., 98.0%, CDAISMWEOUEBRE-GNIYUCBRSA-N, CDAISMWEOUEBRE-GPIVLXJGSA-N, CDAISMWEOUEBRE-LOLGQZEGSA-N, CDAISMWEOUEBRE-NIPYSYMMSA-N, CDAISMWEOUEBRE-OQYPVSDDSA-N, 1,2,3,4,5/6-cyclohexanehexol, 1,2,3,4/5,6-cyclohexanehexol, 1,2,3/4,5,6-cyclohexanehexol, 1,2,4,5/3,6-cyclohexanehexol, DTXSID101028818, DTXSID101028820, DTXSID201028823, DTXSID301028826, DTXSID601028825, DTXSID901028824, HMS2091N13, HMS2230N03, HMS2235H05, HMS2235M23, HMS3369B06, HMS3369F20, HMS3373E05, Pharmakon1600-01500352, D-CHIRO-INOSITOL [USP-RS], D-CHIRO-INOSITOL [WHO-DD], BCP25172, HY-B1411, HY-N3021, MYO-INOSITOL [EP MONOGRAPH], NSC25142, NSC55558, Tox21_111642, Tox21_302035, CCG-36096, cis-Inositol, >=98.0% (TLC), MFCD00799555, MFCD01321249, NSC 55552, NSC 55558, NSC-45517, NSC103959, NSC127230, NSC757076, s4530, STL453612, epi-Inositol, >=98.0% (HPLC), 1,2,3,4,5,6/0-cyclohexanetetrol, AKOS006240678, AKOS006332036, AKOS015895894, AKOS015912905, AKOS015912934, AKOS015960429, AKOS015960633, AKOS015994742, AKOS024318869, AKOS027320475, AKOS027327401, Tox21_111642_1, CS-4782, CS-W010757, CS-W017225, DB03106, DB13178, DB15350, HY-W010041, HY-W016509, HY-W021265, HY-W127726, J9.771C, KS-1284, KS-1420, NSC 103959, NSC 127230, NSC-757076, SB44732, SB45039, SB46764, SB46855, D-chiro-Inositol, >=98.0% (HPLC), NCGC00159409-03, NCGC00159409-04, NCGC00159409-07, NCGC00159409-08, NCGC00169828-01, NCGC00178580-01, NCGC00178580-03, NCGC00255362-01, AC-11070, AS-10616, AS-68396, AS-68424, cyclohexane-1R,2R,3S,4S,5R,6S-hexol, LS-13189, NCI60_041778, SY060836, myo-Inositol, purum, >=98.0% (HPLC), rac-chiro-1,2,3,4,5,6-cyclohexanehexol, SBI-0051369.P003, cis-1,2,4-trans-3,5,6-Cyclohexanehexol, DB-051583, DB-051584, DB-054642, HY-121962, J101.888D, J101.889B, J101.892B, myo-Inositol, for microbiology, >=99.0%, CS-0023004, CS-0039882, CS-0083766, CS-0185922, CS-0369552, I0040, I0628, I0629, I0630, I0631, I0632, I0633, NS00007581, NS00074234, NS00079417, NS00079658, NS00080052, NS00080101, NS00080335, S6176, EN300-82941, myo-Inositol, BioUltra, >=99.5% (HPLC), myo-Inositol, SAJ special grade, >=99.0%, myo-Inositol, Vetec(TM) reagent grade, 99%, C00137, C06151, C06152, C06153, C19891, D08079, D78450, D91187, D91188, D91189, E78671, EN300-658805, F19572, I-6500, M01914, T72516, AB00051982_13, EN300-7361851, EN300-7411506, A836375, EN300-19631206, EN300-19632288, EN300-25914216, Q407997, Q743661, Q-201583, Q2838375, Q2974313, Q3011024, Q3023527, Q3205874, Q3331426, Q3347078, Q3589114, SR-05000001655-1, SR-05000001655-5, W-202861, W-202862, W-203081, W-203168, W-203392, 1,2,4/3,5,6-Cyclohexane-1,2,3,4,5,6-hexol, 7B0CEF84-D9CE-4A88-AA7D-EC50C89387A5, BRD-K52618540-001-09-9, 1D7A27BF-6060-4FA9-AC46-3BD18DBA406E, 220128F1-89BF-442D-AD6D-E6D1EA7BA625, Z1486007281, (1r,2r,3r,4r,5r,6r)-cyclohexane-1,2,3,4,5,6-hexaol, (1R,2S,3r,4R,5S,6r)-cyclohexane-1,2,3,4,5,6-hexol, (1R,2S,3s,4R,5S,6s)-cyclohexane-1,2,3,4,5,6-hexol, epi-Inositol; Inositol, epi- (8CI); epi-Cyclohexanehexol, Inositol, United States Pharmacopeia (USP) Reference Standard, myo-Inositol, European Pharmacopoeia (EP) Reference Standard, rel-(1S,2s,3s,4s,5s,6s)-cyclohexane-1,2,3,4,5,6-hexaol, 1,2,3,4,5,6-Cyclohexanehexol, (cis,cis,cis,trans,cis,trans)- #, 1,2,3,4,5,6-cyclohexanehexol, (1alpha,2alpha,3alpha,4beta,5alpha,6beta), Inositol, Pharmaceutical Secondary Standard; Certified Reference Material, 1.ALPHA.,2.ALPHA.,3.BETA.,4.ALPHA.,5.BETA.,6.BETA.-CYCLOHEXANEHEXOL, 2H3, myo-Inositol, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture
Back